Verum Partners LLC Buys 44 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Verum Partners LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,575 shares of the healthcare conglomerate’s stock after acquiring an additional 44 shares during the period. Verum Partners LLC’s holdings in UnitedHealth Group were worth $921,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Harbor Investment Advisory LLC grew its position in shares of UnitedHealth Group by 3.2% in the first quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after purchasing an additional 1,129 shares in the last quarter. Austin Private Wealth LLC grew its position in UnitedHealth Group by 9.8% in the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock worth $573,000 after acquiring an additional 111 shares during the period. Capital Insight Partners LLC raised its position in UnitedHealth Group by 3.8% in the first quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock valued at $4,475,000 after purchasing an additional 332 shares during the period. Collective Family Office LLC increased its stake in UnitedHealth Group by 4.3% during the 1st quarter. Collective Family Office LLC now owns 1,577 shares of the healthcare conglomerate’s stock worth $780,000 after buying an additional 65 shares during the period. Finally, Global Assets Advisory LLC acquired a new position in UnitedHealth Group during the 1st quarter worth $282,469,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 2.2 %

Shares of UnitedHealth Group stock traded up $12.49 during trading on Wednesday, hitting $568.78. The stock had a trading volume of 1,026,889 shares, compared to its average volume of 3,939,391. The stock has a 50 day simple moving average of $584.11 and a 200 day simple moving average of $532.57. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $523.50 billion, a PE ratio of 34.77, a P/E/G ratio of 1.66 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter last year, the firm earned $6.56 earnings per share. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.48%. UnitedHealth Group’s payout ratio is 51.34%.

Analysts Set New Price Targets

A number of brokerages recently weighed in on UNH. Wells Fargo & Company increased their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. KeyCorp initiated coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price for the company. Morgan Stanley cut their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday. UBS Group upped their target price on UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a research note on Thursday, July 18th. Finally, Barclays lifted their price target on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Two equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $614.74.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.33% of the stock is currently owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.